BLTE
Belite Bio·NASDAQ
--
--(--)
--
--(--)
BLTE fundamentals
Belite Bio (BLTE) released its earnings on Mar 2, 2026: revenue was 0 (YoY --), met estimates; EPS was -0.38 (YoY -18.75%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.38
-18.75%
Report date
Mar 2, 2026
BLTE Earnings Call Summary for Q4,2025
- **FDA NDA submission Q2 2026; 36% lesion growth reduction vs. placebo, 72-75 subjects enrolled in DRAGON II.
Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Belite Bio (BLTE) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Belite Bio (BLTE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Belite Bio (BLTE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Belite Bio (BLTE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Belite Bio (BLTE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Belite Bio (BLTE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Belite Bio's gross profit margin?What were the key takeaways from Belite Bio’s earnings call?What guidance did Belite Bio's management provide for the next earnings period?What does Belite Bio do and what are its main business segments?What is the revenue and EPS growth rate for Belite Bio year over year?Did Belite Bio beat or miss consensus estimates last quarter?What is the market's earnings forecast for Belite Bio next quarter?What factors drove the changes in Belite Bio's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
